The following is a published
clinical case study for clients who want to learn more about specific
endermologie treatment for Fibromyalgia:
The Treatment of a Client Diagnosed with Fibromyalgia Syndrome
Utilizing Integrative Manual Therapy
Author: Tammy S.
Koch, M.P.T., I.M.P., C and Laurie Lunn, P.T.
This study is
published at the following link:
http://www.centerimt.com/e-journal/articles/ej00010.htm
Abstract:
This article is a case study on a 46 year old woman with complaints of total
body pain and diagnosis of Fibromyalgia Syndrome (FMS). This study illustrates
the benefits of Integrative Manual Therapy (IMT) on a client with FMS. The
woman was treated with IMT with a focus on the immune system and lymphatic
drainage. The woman was also treated with Endermologie. After therapy was
completed, the woman had significant improvement including a decrease in her
medications and a significant improvement in levels of fatigue.
Key
Words: Fibromyalgia Syndrome, Chronic Pain, Sleep, Fatigue, Endermologie
Introduction: Modern healthcare has succeeded in markedly
reducing the mortality of the U.S. population. While primary healthcare
research has focused on decoding the genetic mystery which defines chromosomal
predisposition to disease, all aspects of healthcare continue to look for
answers to the chronic diseases and disorders which now account for 80% of all
deaths and 80% of all morbidity. (1) Some of the most challenging chronic
disease patients who visit healthcare providers are diagnosed with fibromyalgia
syndrome (FMS).
FMS was first recognized in the mid 19th century when
physicians noted exaggerated tenderness to palpation in patients. (2) In the
early 1900s, physicians noted inflammation in microscopic examination of
connective tissue. Unable to determine the etiology of this inflammation,
physicians thought the disease was a result of neurosis or hysterical
disorders. (3) This appears to be the beginning of a long history of
misunderstanding clients diagnosed with FMS. Fibrosis and psychogenic
rheumatism were the terms used to describe clients with this disorder prior to
the1980s. In the early 1980s, the term Fibromyalgia
Syndrome was coined by Hench. (4)
Today, FMS is the third leading
diagnosis of those clients visiting the rheumatologists office. (5) The
American College of Rheumatology states that it is 7 times more prevalent in
women than men. (6) The onset of FMS is common between the ages of 20-40 and
diagnosed at a median age of 34-53. (7) There is some speculation that there is
a genetic basis to this disease because of the familial patterns noted,
however, there is no genetic discovery to date which substantiates this
speculation.
Symptoms of FMS vary widely. Musculoskeletal symptoms
reported include: aches, stiffness, swelling (in soft tissue, articular and/or
periarticular areas), tender points (in the neck, shoulders, upper chest wall
and lower back), and muscle spasms or nodules. (8) Other symptoms and/or
concomitant diagnoses include: excessive fatigue, nonrestorative sleep, tension
and migraine headaches, chest pains, irritability, dysmenorrhea, parasthesia,
Raynouds Phenomenon, bowel/bladder irritability, anxiety, depression,
extremity swelling and numbness, total body weakness, mitral valve prolapse,
temporomandibular joint (TMJ) dysfunction, cognitive problems, vertigo,
irritable bowel syndrome, tinnitus, bursitis, reticular skin discoloration,
tachycardia, rheumatoid arthritis, sciatica and lupus. (9, 10, 11)
In
1990, the American College of Rheumatology concluded that fibromyalgia would be
diagnosed by a history of widespread pain occurring longer than 3 months, in
combination with pain in at least 11 of 18 specified bilateral tender points
primarily in muscular tissue origin. (12) Tenderpoints are palpated using a 4
kg/cm2 pressure at these points. (13) Grading of pain occurs according to
Reeves, et al. Index (14) of the following:
0 = no tenderness with no
withdrawal 2 = tenderness and withdrawal 3 = tenderness and exaggerated
withdrawal 4 = untouchable
The etiology of FMS is currently
unknown, although, several postulates abound. Current theories regarding the
etiology include the following:
- Viral infections have been suspected, however no
correlative data has proven this theory to date. Current research is
investigating Espstein Barr, HIV, parovirus, B12 deficiency, and Lymes
disease as possible origins or triggers to FMS. (15)
- Sleep disorders have been heavily suspected. FMS patients
have been observed to experience about a 60% alphawave intrusion of non-REM
sleep. This is 35% higher than observed in control subjects. (16)
- Autonomic nervous system involvement is also suspected as
part of the etiology. Some researchers suspect that muscle tissue
microcirculation alterations may be the cause of muscle tissue hypoxia and may
explain subsequent discomfort which occurs and exacerbates with exercise.
(17)
- Biochemical etiology has been postulated by many. While
researchers are investigating the involvement of tryptophan and its role as a
serotonin precursor, others postulate that Substance P, a neuropeptide involved
in pain transmission, may be the causative reason for FMS. (18)
- Endocrine disorders have been suspected to include: 1)
low levels of growth hormone, somatomedia C; and 2) wide speculation of
hypothyroidism in clients with FMS. (19)
Even today as researchers try to understand the causes of
FMS, many openly dispute whether or not this chronic disease is a psychogenic
disorder or the somatic expression of a major psychologic disorder. Debate
remains as to the causal effect of any psychologic abnormality vs. the onset of
psychologic disorders, mainly depression, which may manifest due to dealing
with the life altering affects of FMS. Treatment of FMS is multidimensional.
Typical treatment includes: education, stress-management, energy conservation,
and cognitive training. Many FMS clients depend on mounting varieties of
medication to address pain control, sleep disturbances, and depression.
Exercise is also a primary treatment approach. The exercise focuses mainly on
low impact and low-level cardiovascular exercise, such as walking or aquatic
therapy. In the past year, physicians have investigated the prevalence of
Arnold Chiari Syndrome and spinal stenosis, which impinge on the brainstem. As
a result, surgeons are doing radical surgery of skull decompression to relieve
pressure on the brainstem. (20) This radical surgery has to date no good
long-term data to suggest it has been beneficial to clients who have undergone
the procedure. While the treatments described above are varied, there is no
treatment or combinations of treatment, to date, which successfully treat FMS.
The objective of this case study is to document the efficacy and
efficiency of using Integrative Manual Therapy (IMT), which may be used
by any health professional whom has attended formal training approved by
Dialogues in Contemporary Rehabilitation, and Endermologie, a form of manual
lymph drainage, (45) to successfully address a client with FMS. The treatment
rationale for using IMT is that treating the structural components of the body
and improving lymph drainage will improve the detoxification process of the
body, positively affect the autonomic nervous system, and thereby improve the
clients function and quality of life. The anticipated outcome was
twofold: 1) subjective reports of decreased pain with improved function, and 2)
objective improvements documented in range of motion, posture, gait, and
cardiovascular endurance.
Case Description: The client was a 46
year old female who came to our facility with complaints of total body pain in
the face, neck, back, chest/rib cage, bilateral shoulders, bilateral upper
extremities, abdomen, low back, hips, buttocks, bilateral lower extremities,
and bilateral feet. She also complained of abnormal sleep patterns and low
endurance to any type of activity. Her medical history was significant for FMS,
Bells Palsey and dental work. She had a history of traumatic injury with
a fractured right arm at 9 years old; four major falls at 21 years of age and a
fall 2 years ago on ice. She is employed 35 hours per week as a librarian.
Although she was completing her work duties, she was experiencing significant
pain and fatigue making the completion of those duties difficult. She had a
long history of total body pain. On evaluation, she was taking the following
medications: Talaren, Baclofen, Oxycontin, Celebrex, Neurontin, Trazodon e,
Tylenol 3, Prilosec, Sulcralfate and Paxil. Treatment this client had used in
the past included a traditional physical therapy exercise program, ju jit su,
massage and bodywork. While these treatments seemed to pallitively decrease
symptoms, she had not seen an overall improvement in her condition and had not
seen changes lasting longer than a few days previous to our intervention.
Evaluation: A comprehensive evaluation was performed on the
client by a physical therapist certified in IMT. Significant findings included
the following:
Posture: severe forward head and neck, bilateral
shoulder protraction and elevation, decreased lumbar
lordosis.
Biomechanics and Joint Mobility: mobility testing
revealed hypomobility at the pelvic joints, lumbosacral junction,
intervertebral joints of the lumbar, thoracic, and cervical spine and OA/AA
joints. Bilateral shoulder and knee joints exhibited moderate limitations in
range of motion (ROM) on all planes. The bilateral hip and ankle joints
exhibited severe limitations in ROM on all planes.
Spinal
Limitations in ROM: (True, uncompensated ROM) Lumbar motion limited by:
flexion - 95 % extension - 95% right lateral flexion- 90% left lateral flexion
- 90% right rotation - 90% left rotation - 90% Cervical motion limited by:
flexion - 75% extension - 75% right rotation - 75% left
rotation - 75% right lateral flexion - 70% left lateral flexion - 70%
Soft Tissue Flexibility: Fascial dysfunction, with limited soft
tissue mobility and pain on palpation was present in the following areas: neck,
suboccipital region, posterior soft tissues of the neck/thorax/lumbar spine,
shoulder girdles, rib cage, abdomen, pelvis/buttocks, upper and lower
extremities, and feet. This soft tissue dysfunction appeared to be contributing
to the limitation in ROM of the spine and extremities. Protective muscle spasm
was also found in the following areas: craniofascial region, neck,
sub-occipital musculature, paravertebral muscles of the neck/thorax/lumbar
spine, bilateral shoulder girdles, rib cage, abdomen, pelvis/buttocks,
bilateral upper and lower extremities and feet. This protective muscle spasm
also appeared to be contributing to the pain and limited ROM.
Clinical Neurology: Light touch sensation was within normal
limits. The brachial plexus showed signs of being compromised at the scalenes
on both the left and right sides.
Strength: Gross muscle
strength for the trunk and all 4 extremities was within functional limits,
however, was painful with testing.
Function/ADLs: The following
activities, as reported by the client, were noted to be painful and difficult:
lying on her stomach, back, or left side; moving from lying to sitting, sitting
to standing, and standing to sitting; sitting; driving; sitting in a car;
walking; bending; lifting; reaching; work activities. The client also noted
sports and leisure activities were compromised. The client reported both pain
and low endurance/quick fatigue were limiting factors in these activities.
Gait: Decreased reciprocal movements at bilateral upper
extremities and trunk; decreased stride length bilaterally. The client noted
she could only walk short functional distances secondary to a significant
increase in severe and prolonged total body pain following the activity.
Girth Measurements: Waist/Umbilicus: 53 inches Right thigh: 26
inches Left thigh: 26 inches
Myofascial Mapping: (21)
Significant Mapping noted over lymph tissue, abdomen, and thorax.
Intervention: After a full explanation of the objective findings
to the client, she was further educated on IMT, the various treatment
techniques and rationales and her responsibilities as our client towards her
improved health and recovery. Throughout the course of treatment, the client
was continually educated regarding the treatment and its rationale.
Treatment goals included: decreased pain, improved biomechanical and
joint dysfunction, decreased protective muscle spasm, increased soft tissue
flexibility with decreased fascial dysfunction and increased ROM; return to
previous activities and functional level with normal endurance and no pain.
The treatment plan was developed after reviewing the evaluation and
included multiple techniques from the Integrative Manual Therapy approach. With
significant Myofascial Mapping noted over the lymph tissue, thoracic and
abdominal regions, Disruption of Membrane technique (22) was completed over
areas of the kidneys, inferior vena cava (IVC), superior vena cava (SVC),
thoracic duct, sigmoid colon, portal system and liver. Superior and inferior
vena cava syndromes (23) were also completed. Lymph node Advanced Strain and
Counterstrain techniques (24) were done in areas of major lymph nodes and near
major organs. Aberrant motilities in the lower extremities, abdomen and thorax
were addressed to include Immune Deficiency Motility (25) and Eruption
Motility. (26) Endermologie was completed 7 times over the total body to
enhance lymph drainage throughout the body. Compression Syndromes (27) were
done on the lower extremities and the Bone Bruise technique (28) was used on
the femur, tibias, ribs, cranium, ilia and the spine. Advanced Neural Tissue
Tension Techniques (29) to sensory nerves of the upper extremities and cranial
base was utilized. Muscle Energy and Beyond Techniques were used to
address pelvis and sacrum mechanics. All of the above mentioned techniques were
completed in approximately 33 visits. During the course of treatment, the
client asked her physician for assistance in safely decreasing her medications
according to his guidelines. Functionally, the client was educated in
completing a walking program beginning with 2-5 minutes of walking. She was
then instructed in adequate progression of this program.
Neurofascial
Process homework was issued to the client for self-treatment. (30) Imagery was
used to help the client with psycho/social/emotional issues which arose during
the course of treatment.
Outcomes: Following completion of the
aforementioned treatment, the client subjectively reported the following:
- A reduction of all medications by 2/3s including a
reduction of Neurontin from 900 mg/day to 200 mg/day secondary to decreased
pain.
- Decreased pain as follows: upper back pain decreased from
12/10 to 0/10; wrist pain decreased from 10/10 to 2-3/10; bilateral lower
extremity pain decreased from 7-8/10 to 2/10. (these are based on a 0-10
subjective pain scale)
- A decrease in fatigue, as evidenced by her improved
productivity with household ADLs. Increased endurance to complete work
activities/duties and a report of being more alert at work.
- Increased endurance: both the client and her husband
reported that she no longer comes home from work and immediately falls asleep.
- Decreased duration of headaches from lasting 2-3 days
prior to treatment to now lasting approximately 2 hours. Client also notes
frequency of headaches has decreased.
- Decreased pain and spasms in face and neck. Previous to
this treatment, client reported 3-4 spasms with pain per week. Currently, the
client reports 1 spasm with pain every 3-4 weeks.
- Increased ability to stand for prolonged periods of
time, which allows her to complete work, home and social activities.
- Improved tolerance for walking. Previous to treatment,
walking for cardiovascular exercise caused severe and prolonged reactive pain
in the entire body. The client is now able to walk up to 10-15 minutes a day
with no increase in pain.
- Decrease in Bells Palsy symptoms, as evidenced by
improved expressive movements of the face.
- Fluid reduction, as evidenced by a decrease in clothes
size by 1 full size, despite no diet change.
Objective findings were noted as follows:
| 1. Decrease in girth measurements |
in inches |
|
Before |
After |
| waist/umbilicus |
53 |
48 |
| bilateral thighs |
26 |
24 |
|
| 2. Spinal ROM Improvements |
Percentage Limitation
|
| |
Before |
After |
| lumbar flexion |
95 |
50 |
| lumbar extension |
95 |
75 |
| lumbar sidebending |
90 |
65 |
| cervical flexion |
75 |
60 |
| cervical extension |
75 |
70 |
| cervical rotation |
75 |
50 |
|
3. Improved ROM in right shoulder from moderate
functional and goniometric loss to mild limitations.
4. Improved
cardiovascular endurance, as evidenced by her ability to tolerate progressive
functional distances walked.
5. Improved posture, as evidenced by a
decrease in the forward head posture, increased lumbar lordosis and decreased
protracted shoulders.
6. Improved gait noted with increased stride
length and reciprocal upper extremity movement, which is also indicative of
improved lumbosacral movement.
Discussion: The results of this
single case report using Integrative Manual Therapy techniques and Endermologie
suggest that the anatomical specific identification of pathoanatomy can
successfully be used to provide favorable outcomes for clients with FMS. A
review of the literature has determined that while the American Association of
Rheumatology has determined basic guidelines for diagnosis, there is no
effective treatment aimed at uncovering the pathoanatomy and etiology unique to
each individuals case. Therefore, developing a treatment plan aimed at
treating the possible pathoanatomical causes behind the symptoms of FMS had not
been developed until the evaluation and treatment techniques of IMT were
introduced. IMT evaluation and treatment techniques allow for specific and
successful clinical diagnosis of pathoanatomical landmarks and treatment of
each individual clients situation.
Roger Williams, Ph.D., the
author of Biomechanical Individuality, states that anatomy and biochemistry are
always intimately related, even though the two disciplines may be regarded as
quite dissimilar. (31) While Dr. Williams saw anatomical variations rooted
primarily in heredity, the theory of IMT would support the hypothesis that the
anatomical variations between individuals is, in part, due to breakdown of
tissue secondary to antigens and protective mechanisms facilitated by the
brainstem. These would, in turn, affect the efficiency and function of the
anatomical structure, thereby affecting the bodys biochemistry.
This case study treatment plan considered several anatomical systems to
assist the clients body in detoxifying and healing. The lymphatic system
was a major focus of the treatment plan. It was addressed through treatment of
lymph nodes with Advanced Strain and Counterstrain Technique, Disruption of
Membrane Technique, and Endermologie treatment. All were used to enhance lymph
drainage. Ingrid Kurz, MD, states that lymph drainage activates inhibitory
cells whose function is to dampen the sensation of pain. (32) Furthermore, she
states that lymph drainage has immunological benefits assisting the body in
inactivating antigens by mobilizing the function of the lymph system. (33)
These things said, we can then hypothesize by extrapolation that treatment of
the lymph system assists in function of this system, thereby assisting the
bodys healing, detoxification, and pain relief.
Lymphatic
drainage was completed using Endermologie. This treatment was performed to the
entire body and at times focused on areas of congestion such as the lower
extremities. Dr. Vodder reports that the effects of lymph drainage are to not
only improve the immune system and drainage effectiveness of the system, but
that lymph drainage has a stimulating effect on the parasympathetic nervous
system with resultant subject calmness and relaxation. (42) This is important
in a world that continually challenges the sympathetic nervous system through
daily stress, bringing it to a heightened state of resting potential. In an
individual whose body is doing its best to survive, one may expect the
sympathetic nervous system to be at a heightened state of alert. Lymphatic
drainage starts the process of balancing the autonomic nervous system. This
attempt at balancing the autonomic nervous system was further supported through
Neurofascial Process homework and imagery.
Dr. Vodder also reports that
lymph drainage has a tonic effect on smooth muscles of the blood vessels. (43)
Once the sphincters of these vessels close, the capillary pressure drops. (44)
As a result, there is improved edema reduction and reabsorptive capacity of the
capillaries. Therefore, the capillaries become a more efficient means of
drainage throughout the tissue system. This will also impact the amount of
blood delivered to the muscles with activity. Functionally, the impact will
allow increased tolerance to exercise.
Dr. W. Giammatteo reports that
both the IVC and the SVC are important for effective lymphatic drainage to
occur. (35) Furthermore, she reports that the IVC is clinically more
significant than the SVC for lymphatic drainage due to its importance in
gastrointestinal lymphatic drainage. (36) This client had significant and
thorough IMT work done to focus on both the IVC and SVC. The theory being that
both would again enhance the lymphatic drainage and improve detoxification. Dr.
Kurtz reports in her book, Introduction to Dr. Vodders Manual Lymph
Drainage, that while the arterial network is the supply system to the tissues,
the venous and lymph systems network the drainage systems. (37) The venous
system has the task of removing small molecules from the connective tissue and
transporting them. (38) The lymph system removes larger molecules and water
from tissue and transports them. (39) According to Vodder, lymph obligatory
load, those substances which must be removed by the lymph system, includes the
protein molecules, immobile cells, cell fragments, waste product, bacteria,
viruses, inanimate substances, surplus water and large molecular fats. (40)
When in a protective mode due to injury or an infectious process, the IVC is
not capable of maximizing the detoxification process potential. Toxins will
remain in the system with the expected inflammatory response occurring, thus
impacting the clients function. The SVC receives lymph flow from all
areas except the right thoracic inlet, abdominal region and bilateral lower
extremities. Dr. W. Giammatteo reports that restrictions in the SVC flow will
cause congestion with subsequent impact on the immune system and the cardiac
system. (41) Impact on both the immune and cardiac systems will therefore
decrease function of each system via decreased ability to fight antigens and
decreased cardiovascular endurance. IMT techniques for the liver and portal
system were completed: structural work was done on these anatomical parts to
improve the function of the system and therefore further assist the bodys
ability to detoxify. Phase I activation and Phase II conjugation are functions
of the liver which remove exogenous and endogenous toxins from the body through
detoxification. (34) Functional biochemical tests to determine the
effectiveness of these detoxification processes would have been of interest pre
and post treatment with IMT to objectively determine improvement in this
clients ability to detoxify.
In attempts to decrease the
clients pain, Bone Bruise technique and Advanced Neural Tissue Tension of
the sensory nerves were completed in areas of intense discomfort. By completing
these techniques, the body was able to maximize healing potential, and pain
receptors were subsequently quieted. The client was able to decrease her
medication dramatically secondary to improved comfort. As soft tissue
protection was relaxed through the aforementioned techniques, the biomechanical
range of motion potential was maximized through Muscle Energy and
Beyond Technique of the pelvis, sacrum and spine. This allowed for
improved ease and comfort with function, which was evident in ROM testing pre
and post treatment.
Conclusion: This single study case study has
demonstrated the successful use of Integrative Manual Therapy techniques to
evaluate and treat the diagnosis of fibromyalgia syndrome efficiently and
effectively. Clearly, it shows that the treatment of FMS occurs most
effectively when the theory of toxicity is considered, and attempts are made to
assist the body in healing and detoxification by focusing on the
pathoanatomical landmarks of multiple systems. With IMT, each clients
condition is unique, and subsequent treatment plans which focus on the
pathoanatomical landmarks involved in that clients condition can help to
improve their health, and ultimately, their quality of life.
References: www.nidr.nih.gov/slavkin/slav1197.htm,pg1.
www.nidr.nih.gov/slavkin/slav1197.htm.pg2.
www.nidr.nih.gov/slavkin/slav1197.htm,pg3.
www.ptjournal.org/pt_journal/Jan97/krnich.htm,pg1.
www.ptjournal.org/pt_journal/Jan97/krnich.htm,pg1.
www.neruologychannel.com/fibromyalgia/pg.1. Boissevain MD, McCain GA,
Toward an integrated understanding of fibromyalgia syndrome, I: medical and
pathophysiological aspects. Pain. 1991:44:pg. 228.
www.ptjournal.org/pt_journal/Jan97/krsnich.htm,pg.1.
www.ptjournal.org/pt_journal/Jan97/krsnich.htm,pg.1
www.neruologychannel.com/fibromyalgia/pg.2
www.nidr.hih.gov/slavkin/slav1197.htm,pg3.
www.nidr.nih.gov/slavkin/slav1197.htm,pg3.
www.ptjournal.org/pt_journal/Jan97/krsnich.htm,pg2.
www.ptjournal.org/pt_journal/Jan97/krsnich.htm,pg2.
www.ptjournal.org/pt_journal/Jan97/krsnich.htm,pg4. Boissevain MD, McCain
GA. Toward an integrated understanding of fibromyalgia syndrome, I: medical and
pathophysiological aspects. Pain.1991:44:233. 17. Goldenberg DL. Controversies
in fibromyalgia pain syndrome. In: Arnoff GM, ed. Evaluation and Treatment of
Chronic Pain, Md: Williams and Wilkins: 1992:165-75. 18
www.neurologychannel.com/fibromyalgia/pg.2. 19.
www.ptjournal.org/pt_journal/Jan97/krsnich.htm,pg.4. 20.
www.wholehealthmd.com/news/viewarticle/o,1513,1046,00.html,pg.1. 21.
Myofascial Mapping, DCR, Kris Albrecht, M.S., P.T., Instructor, May 3, 1998.
22. Visceral Mobilization with Muscle Energy and Beyond
Technique: Focus on the Gastrointestinal Tract (A Lab Course), Tom Giammatteo,
D.C., P.T., Instructor; Sharon Weiselfish-Giammatteo, Ph.D., P.T., Instructor,
April 23-25, 1999. 23. Weiselfish-Giammatteo, Ph.D., P.T., Sharon,
Intensive tutorial, 2000. 24. Lymph 1, DCR, Sharon Weiselfish-Giammatteo,
Ph.D., P.T., Instructor, July, 2000. 25. Visceral Mobilization with Muscle
Energy and Beyond Technique: focus on the Gastrointestinal Tract (A
Lab Course), Tom Giammatteo, D.C., P.T., Sharon Weiselfish-Giammatteo, Ph.D.,
P.T., Instructors, April 1999. 26. Weiselfish-Giammatteo, Ph.D., P.T.,
Sharon, Intensive tutorial, 2000. 27. Lower Extremity Compression
Syndromes, DCR, Kris Albrecht, P.T., I.M.P.,C., Instructor, August 24-26, 1999.
28. Type III Dysfunction of the Spine and Extremity Joints with Muscle
Energy and Beyond, DCR, Rosemary Hegarty, P.T., I.M.P.,C., Instructor,
September 24-26, 1999. 29. Neural Tissue Tension, Kris Godikson,
Instructor, May 1999. 30. Integrative Diagnostics, Part I, Sharon
Weiselfish-Giammatteo, Ph.D., P.T., February 1999. 31. Williams, Roger J.
Ph.D., Biochemical Individuality, New Canaan, CT: Keats Publishing, 1956, pg.
19. 32. Kurz, Ingrid Md, Introduction to Dr. Vodders manual Lymph
Drainage Vol. 2: Therapy I, Heidelberg: Karl F. Haug, Publishers, 1986, pg. 29.
33. Kurz, Ingrid Md, Introduction to Dr. Vodders manual Lymph
Drainage Vol. 2: Therapy I, Heidelberg: Karl F. Haug, Publishers, 1986, pg. 29.
34. Bland, Jeffery, Clinical Nutrition: A Functional Approach, Gig Harbor:
The Institute for Functional Medicine, 1999, pg. 46. 35. Lymph I, DCR,
Sharon Weiselfish-Giammatteo, Ph.D., P.T., Instructor, July, 2000. 36.
Lymph I, DCR, Sharon Weiselfish-Giammatteo, Ph.D., P.T., Instructor, July,
2000. 37. Kurz, Ingrid Md, Introduction to Dr. Vodders manual Lymph
Drainage Vol. 2: Therapy I, Heidelberg: Karl F. Haug, Publishers, 1986, pg. 35.
38. Kurz, Ingrid Md, Introduction to Dr. Vodders manual Lymph
Drainage Vol. 2: Therapy I, Heidelberg: Karl F. Haug, Publishers, 1986, pg. 42.
39. Kurz, Ingrid Md, Introduction to Dr. Vodders manual Lymph
Drainage Vol. 2: Therapy I, Heidelberg: Karl F. Haug, Publishers, 1986, pg. 42.
40. Kurz, Ingrid Md, Introduction to Dr. Vodders manual Lymph
Drainage Vol. 2: Therapy I, Heidelberg: Karl F. Haug, Publishers, 1986, pg. 42.
41. Lymph I, DCR, Sharon Weiselfish-Giammatteo, Ph.D., P.T., Instructor,
July, 2000. 42. Kurz, Ingrid Md, Introduction to Dr. Vodders manual
Lymph Drainage Vol. 2: Therapy I, Heidelberg: Karl F. Haug, Publishers, 1986,
pg. 25. 43. Kurz, Ingrid Md, Introduction to Dr. Vodders manual Lymph
Drainage Vol. 2: Therapy I, Heidelberg: Karl F. Haug, Publishers, 1986, pg. 30.
44. Kurz, Ingrid Md, Introduction to Dr. Vodders manual Lymph
Drainage Vol. 2: Therapy I, Heidelberg: Karl F. Haug, Publishers, 1986, pg. 31.
45. Integrative Diagnostics Series, Level 3, DCR, Sharon
Weiselfish-Giammatteo, Ph.D., P.T., Instructor, October, 2000. |